Cahill Thomas's Form 4 filing
Prime Medicine, Inc. (PRME) · filed Oct 26, 2022
- Accession no.
- 0001628280-22-027122
- Filed
- Oct 26, 2022
- Trade date
- Oct 24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $6.80M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cahill ThomasCIK 0001922939 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 | Common Stock | CConversionAcquired | +4,905,679 | – | – | 4,905,679 | Indirect | |
| Oct 24, 2022 | Common Stock | PPurchaseAcquired | +400,000 | $17.00 | +$6,800,000 | 5,305,679 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2022 | Common Stock | CConversionDisposed | −3,216,674 | $0.00 | $0 | 0 | Indirect | |
| Oct 24, 2022 | Common Stock | CConversionDisposed | −1,689,005 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.